Nyxoah announced that the company has signed a strategic partnership to become a Corporate Champion at the ENTerprise Circle level with the American Association of Otolaryngology – Head & Neck Surgery Foundation, or AAO-HNSF. Nyxoah is the first medical device company to partner with the AAO-HNSF at this level. The AAO-HNSF is committed to identifying and combating harmful coverage policies that threaten access to quality otolaryngology-head and neck services. The Academy’s Advocacy team, in collaboration with its dedicated members and strategic industry partners like Nyxoah, actively engage with payers to achieve this goal.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH:
- Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology – Head & Neck Surgery Foundation
- Nyxoah price target raised to $27 from $20 at Stifel
- Nyxoah price target raised to $22 from $18 at H.C. Wainwright
- Nyxoah’s Genio System Shows Promise in OSA Study
- Nyxoah announces DREAM study meets primary endpoints
